Ticks pose a grave risk to public health, with nearly half a million cases of the tick-borne Lyme disease treated every year ...

New molecular testing could mean earlier diagnosis and treatment for common vaginal infections. Alberta Precision Laboratories, a subsidiary of Alberta Health Services, is now using molecular ...

The Point of Care (PoC) molecular diagnostics market is forecasted to hit USD 5,295 Million by 2025. Then, it is likely to grow to USD 13,733.8 Million by 2035 with a CAGR of 10% over time. Things ...

Researchers have developed an innovative new nanopore sequencing assay to identify carriers of fragile X syndrome (FXS), the ...

Additionally, the market is advancing as novel, rapid, and precise testing tools. The Americas COVID-19 testing market was valued at around USD 5.8 Billion in 2025, backed by the continued need for ...

This method, outlined in a paper published ... to enable future measurements of the antimatter molecular hydrogen ion H 2-for tests of the fundamental charge-parity-time reversal symmetry ...

Bioluminescent reactions, were light is emitted from a living being, have a lot of potential applications in biomedical ...

A non-DNA based test could identify viral infections in patients in minutes. When a clinician suspects a patient has a viral ...

Cell-free DNA-based liquid biopsies showed promise for monitoring response to pancreatic cancer therapies and making ...

A test using blood and saliva samples could help track aging and guide targeted interventions to maintain mental and physical ...

A groundbreaking blood test can detect multiple cancers early with high accuracy using cell-free DNA analysis.